Klebsiella pneumoniae pathogenesis in the obese lung

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1R03AI151525-01

Grant search

Key facts

  • Disease

    N/A

  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $78,000
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    ASSOCIATE PROFESSOR MATTHEW WARGO
  • Research Location

    United States of America
  • Lead Research Institution

    UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Obesity is a major public health issue and the obese population is steadily increasing. One consequence of obesity is increased susceptibility to bacterial pneumonia. While altered immune function in the lung is an important driver of this susceptibility, the contribution of the bacterial response to the obese lung environment has not been examined. Klebsiella pneumoniae (Kp) is one of the bacteria to which obese individuals are susceptible and is an important drug-resistant pathogen. The goal of this proposal is to examine the bacterial response to the obese lung and use this to better understand host biology and bacterial pathogenesis during infection. Our published preliminary data show increased susceptibility of obese mice to Kp using four different mouse models, three genetic (db/db, ob/ob, and CPEfat/fat) and one high-fat diet-induced (DIO). While all four obese models are more susceptible to Kp than lean littermates, each shows different bacterial growth/survival kinetics in the lung. Each model manifests different degrees of diabetes and other elements of the metabolic syndrome meaning that interaction of the bacteria with each of these models happens in an environment that is likely chemically and immunologically different. Our preliminary data of Kp transcriptome response to db/db bronchoalveolar lavage fluid combined with our published data on host cellular immune defects suggests that host defects are combined with pro-pathogenic bacterial responses to the obese lung environment to promote infection in the lung. The bacterial response in these four obese models will be used to identify Kp genes important for infection of obese mice as well as provide a means to probe altered host physiology, via two Specific Aims: (1) Use the Kp transcriptome response to identify genes contributing to infection in obesity models and (2) Use Kp transcriptomes to identify altered host parameters in the lung. Complete Kp transcriptomes from the four obese models will allow specific dissection of the host-pathogen interface related to obesity, and using Kp as a living probe will uncover altered airspace lining fluid composition in obesity that will vary with the elements and degree of metabolic syndrome expression in each model. The bulk of bacterial-host interaction studies in obesity have focused on deficiencies in the host cellular immune response. Here we will use the transcriptome response of Kp to understand changes to the lung airspace during obesity that alter bacterial gene expression. The ability to compare and test mutant phenotypes in relation to four different models of obesity will allow discovery of new aspects of host-bacterial interactions, and provide a foundation for mechanistic understanding of these interactions.